Plerixafor for Poorly Mobilized Lymphoma
Clinical trial NCT05510544 · UNKNOWN
Trial details
- NCT number
- NCT05510544
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2023-12-20
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.